22 Oct 2018 maja Hronična limfocitna leukemija Chlorambucil, rituximab and lenalidomide combination treatment for patients with chronic lymphocytic leukemia Chlorambucil, rituximab and lenalidomide combination treatment for patients with chronic lymphocytic leukemia This study aimed to evaluate the Read More
22 Oct 2018 maja Hronična limfocitna leukemija Evaluating the safety of ibrutinib in leukemia and lymphoma Evaluating the safety of ibrutinib in leukemia and lymphoma This study looked at the evidence for the safety of ibrutinib (Imbruvica) in the Read More
13 Apr 2018 maja Hočkinov limfom, Hronična limfocitna leukemija, Nehočkinski limfom NIH study revises molecular classification for most common type of lymphoma NIH study revises molecular classification for the most common type of lymphoma Subgroups of DLBCL by gene expression (left) defined Read More
14 Nov 2017 maja Hronična limfocitna leukemija Liver dysfunction at diagnosis can impact survival Liver dysfunction at diagnosis can impact survival This study examined whether the presence of liver dysfunction affects the outcomes of newly Read More
14 Nov 2017 maja Hronična limfocitna leukemija Immune disorder and infection risk in patients with early-stage CLL Immune disorder and infection risk in patients with early-stage CLL This paper studied hypogammaglobulinemia, an immune disorder, in patients Read More